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Pit Viper Envenomation In Dogs: 
Pathophysiology and Treatment 
DAVID SENTER, DVMt, AND TOM CARSON, DVM, PH.D.tt 
Copperhead (Agkistrodon contortix). This species 
enjoys widespread distribution across the U.S., 
ranging from Texas and Oklahoma in the south· 
west, Iowa to the northwest, New York and Massa· 
chusetts to the northeast, and Florida to the south· 
east. This species is among the most commonly 
encountered pit vipers in the U.S., however it is 
also among the least dangerous in terms of venom 
toxicity and volume of injection. 
Venomous snakes occur throughout a very 
wide geographic area within the United 
States. In certain areas of the country, snake-
bites in dogs are diagnosed on a regular basis 
during the warm months of the year when 
snakes are most active and people and their 
pets are most likely to be spending time in 
areas that snakes inhabit. The best treatment 
for snakebite is a controversial subject among 
veterinarians and there is no single treatment 
protocol. Therefore, it is necessary for a clini-
cian to understand the pathophysiology be-
hind envenomation in order to make educated 
decisions as to the treatment of each indi-
vidual patient. 
An estimated 15,000 domestic animals are 
bitten by snakes annually in the United 
States. Approximately 80% of fatal bites are 
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inflicted by rattlesnakes. 1 Members of the 
Crotalidae (pit viper) family account for the 
large majority (95%) of poisonous snakebites. 
The three main genera in this family are Cro-
talus (rattlesnake),Agkistrodon (copperhead, 
cottonmouth water moccasin), and Sistrurus 
(pygmy rattler, massasauga).2 Among these 
groups, there are at least 26 subspecies of 
rattlesnakes, five subspecies of copperheads, 
three subspecies of cottonmouths, three sub-
species of pygmy rattlesnakes, and three sub-
species of massasauga.1 Members of the pit 
viper family get their name from the facial 
pits that exist between the nostril and the eye 
which function to detect heat and vibration. 1,2 
Other distinguishing characteristics of the 
crotalids include triangular shaped heads, re-
tractable fangs, a single row of subcaudal 
scales, and vertical, elliptical shaped pupils. 
All pit vipers have movable fangs that inject 
a voluntarily controlled amount ofvenom.2 
Pathophysiology 
In general, pit viper venom is considered 
hemotoxic and proteolytic as opposed to many 
snakes that are predominately neurotoxic. 3 
The Mojave green rattlesnake (Crotalus 
scutulatus scutulatus) is an exception as its 
venom contains a very substantial quantity 
of neurotoxin. Venom constituents vary con-
siderably between snakes of different species 
as well as between individuals within a spe-
cies depending on geographic location, age, 
and season of the year. 
Of the three genera in the pit viper fam-
ily, the rattlesnakes have the most potent 
venom with the eastern and western diamond-
back rattlesnakes accounting for 95% of fa-
talities in man.2 The relative toxicity of venom 
from several North American snakes are listed 
in Table 1. 
Snake venom consists of a diverse mix-
ture of peptides, enzymes, and proteins. At 
least 26 different enzymes have been defined, 
ten of these are common to all pit viper ven-
oms. One major enzyme is hyaluronidase 
which allows the venom to spread and pen-
21 
Table 1. Venom Toxicity of Some North American Snakes! 
Snake Median Lethal Dose 
Rattlesnakes (Crotalus) 
Mojave (C. scutulatus scutulatus) 
Eastern diamondback (C. adarnanteus) 
Western diamondback (C. atrox) 
Timber (C. horridus horridus) 
Pygmy rattlesnakes (Sistrurus) 
Pygmy (8 . miliaris) 
Massassauga (8 catentatus) 
Moccasins (Agkistrodon) 
Cottonmouth (A. piscivorus) 
Copperhead (A. contortrzx) 
LD50( mg / kg-l}* 
0.23 
1.68 
2.18 
2.69 
2.85 
2.91 
4.19 
10.92 
LD50 values are from a study which adminisU!red venom intravenously in 18 to 26 gm mice. 
etrate tissues by decreasing the viscosity of 
connective tissue. 1,4 Another major component 
is phospholipase ~ which disrupts cell mem-
branes, uncouples phosphorylation, inhibits 
cellullar respiration, and may release hista-
mines, kinins, and serotonin. Phospholipase 
A;, acts by liberating arachidonic acid from 
Prairie rattlesnake, Western rattlesnake, Green 
rattlesnake (Crotalus viridis). This species is 
found in all U.S. states west of a line from the 
Dakotas to Texas. It is a locally common species 
with a variable temperanlent. Despite its rela-
tively small size, envenomation by this species 
has resulted in human fatalities. 
membrane phospholipids which is then con-
verted to various prostaglandins (PGI2, PGE2, 
PGF 2<) and thromboxane A;,.3 Prostaglandin 
E2 and PGI2 cause vasodilation and decrease 
systemic arterial pressure that contributing 
to hypotension. Another component, throm-
boxane A;" is a potent inducer of platelet ag-
gregation which may contribute to thromb-
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ocytopenia. Several attempts to measure the 
amount of histamine released after contact 
with snake venom have been perfQrmed by 
various in vitro tests with mixed results. How-
ever, no in vivo direct test of the histamine-
releasing activity of Crotalus species venom 
has been reported. 3 The nonenzymatic 
polypeptide component of Crotalidae venom 
has more of a direct effect on the cardiovascu-
lar and respiratory system. 
Cardiovascular System 
A lethal factor in Crotalus species venom dis-
rupts the basal lamina and collagen of the 
capillaries allowing for leakage of red blood 
cells and plasma through the endothelial 
membrane. l ,3 Petechia, ecchymosis, and exten-
sive edema are commonly seen due to the vas-
cular destruction and increased vascular per-
meability. Approximately one-third of the total 
circulating fluid volume can be lost into an 
affected extremity within hours of envenoma-
tion. I ,3 Furthermore, severe hypotension com-
monly occurs due to pooling of blood in the 
hepatosplanchnic bed in dogs.4 This combina-
tion can ultimately lead to hemoconcentration, 
lactic acidosis, and hypovolemic shock. 
Some envenomated patients will have 
concurrent thrombocytopenia which may be 
due to the aggregation of platelets to areas of 
damaged endothelium and the production of 
thromboxane A;,and PGE2 from phospholipase 
A;,. Venoms from several species of rattle-
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Mojave rattlesnake, l .. U ..... '., 
(Crotalus scutulatus). Mojave rattlers are 
unique among rattlesnake species in that their 
venom contains a significant neurotoxic compo-
nent. Per volume, this venom is the most highly 
toxic of all the North American pit vipers. This 
species ranges from southwest Utah to south· 
ern Nevada and the Mojave De ert region and 
southward to central Mexico. 
snakes have been shown to have direct plate-
let-aggregating properties.3 
In general, snake venom has very com-
plex effects on blood coagulation. Many ofthe 
rattlesnake venoms studied cause the forma-
tion of an imperfect fibrin clot which results 
in pure defibrination and high levels of fibrin 
degradation products.3 This cause is differen-
tiated from disseminated intravascular coagu-
lation (DIC) by the fact that platelets and fac-
tor VIII are not consumed. Unlike with DIC, 
this condition is not inhibited by heparin. 
Cottonmouth and copperhead venom affects 
coagulation in a different manner. Since their 
venoms interfere with the formation offibrin, 
defibrination does not occur. However, these 
do cause hypofibrinogenemia from the disso-
lution of fibrinogen. 3 Many venoms have 
procoagulant properties and anticoagulant 
properties.4 Nevertheless, the overall effect 
of most severe pit viper envenomations is an 
anticoagulative state. 
Nervous System 
The Mojave rattlesnake is the only member 
of Crotalidae found in North America whose 
venom has a significant neurotoxic compo-
nent. This toxin (Mojave toxin) interferes with 
neuromuscular transmission by a presynap-
tic nerve-blocking action.5 The major toxic ef-
fects involve the peripheral nervous system 
and include respiratory paralysis and general 
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flaccid paralysis. However, its greatest effect 
is on motor axon terminals of the diaphragm 
and respiratory paralysis may not occur for 
several hours after envenomation. 
Urinary System 
Most pit viper venoms, especially those of the 
western diamondback rattlesnake and the 
prairie rattlesnake, cause myonecrosis which 
could cause the release ofmyoglobin.5 There-
fore, if severe envenomation has occurred, the 
nephrotoxic effects of myoglobinuria may re-
sult in acute renal failure. Other potential 
nephrotoxic factors include hemoglobinuria 
(some venoms cause intravascular hemolysis), 
defibrination syndrome, and hypovolemic 
shock. 
Clinical Signs and Diagnosis 
Snake envenomation can be difficult to diag-
nose ifthe incident was not witnessed. Clini-
cal signs may vary greatly depending on the 
species of snake involved and the quantity and 
. toxicity of the venom injected. The potency of 
the venom depends on several factors such as 
age ofthe snake (young snakes have high pep-
tide fractions), the volume of venom regener-
ated since the last bite, aggressiveness of the 
snake, and motivation of the snake (offensive 
strikes are usually more severe).! In addition, 
the enzymatic fraction ofthe venom is higher 
in the fall and lower in the spring in relation 
to the peptide fraction. 
Most bites in dogs involve the head, face, 
or neck.4 Bites to the body rarely occur, but 
tend to involve much more severe envenoma-
tion.! Dogs commonly present with extensive 
edematous swelling, severe pain, ecchymosis, 
and discoloration of the skin in the affected 
area within several hours after the bite. It is 
advisable to clip the hair in the area to search 
for fang marks (one or more with mUltiple 
strikes). Bleeding puncture wounds may in-
dicate the bite of a pit viper.! Iffang puncture 
wounds are present in the absence of pain and 
swelling, the dog may have received a dry or 
nonpoisonous bite. It is estimated that poi-
sonous snakes fail to inject venom in up to 
20% of bites.2 However, some bites by the 
Mojave rattlesnake may be life-threatening 
without pain or swelling.6 All patients should 
be hospitalized and monitored for at least 24 
23 
hours for signs of systemic envenomation. 
Some laboratories can perform blood analy-
sis to determine the concentration and type 
of venom injected, however, this method is not 
routinely used in North America.6.7•8 
Systemic signs can vary and may include 
hypotension, shock, cardiac arrhythmias, 
bleeding disorders, ptyalism, nausea, vomit-
ing, respiratory distress, mental confusion, 
rhabdomyolysis, and acute renal failure. 1.2,6 A 
Timber rattlesnake (Crotalus horridus). This is 
the most common venomous species found in the 
eastern U.S. Its range includes most of the states 
east of the Mississippi River. West of the Missis-
sippi, the Timber rattlesnake is found as far we t 
as Nebraska, Kansas, Oklahoma and Texas, and 
as far north as Minnesota. This is a fairly large 
species, with large adults reaching 5 feet in 
length. Timber rattlers have a large amount of 
venom available for injection, and must cer-
tainly be considered dangerous to animals and 
humans alike. 
baseline oflaboratory data should be obtained 
upon presentation including: complete blood 
count, platelets, coagulation profile (prothrom-
bin time, partial thromboplastin time, fibrino-
gen), serum electrolytes, blood urea nitrogen, 
creatinine, creatine phosphokinase (CPK), 
glucose, and urinalysis. 1 If severe envenoma-
tion is suspected, electrocardiographic moni-
toring should be performed. 
Wright-Giemsa stained blood smears 
should be evaluated in all suspected cases of 
snakebite. A study of 28 cases of rattlesnake 
bites in dogs indicated an association of en-
venomation with echinocytosis; 25/28 dogs 
(89%) had echinocytosis within 24 hours af-
ter the bite.9 Since slow drying of blood films 
can cause the artifactual formation of 
echinocytes (crenation), a saline wet mount 
preparation should be made of both the sus-
pected victim and a healthy, nonenvenomated 
dog for comparison. This prep can be done by 
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mixing a drop of isotonic saline with one drop 
of EDT A-preserved blood on the slide. A cover 
slip is added and the sample observed with a 
light microscope. The ecchinocytosis is a tran-
sient shape change with most cases resolving 
by 48 hours. 
The aforementioned study also reported 
that sixty-four percent of dogs bitten by rattle-
snakes developed thrombocytopenia, 10 of28 
(36%) dogs had mild anemia, and 14 of 18 
(78%) developed hypokalemia.9 Anemia may 
be due to cell destruction following enveno-
mation. The cause of the hypokalemia was 
not apparent, however, it does indicate the 
need for supplementation during treatment;-
On the contrary, hyperkalemia can commonly 
be seen in severe envenomations that cause 
extensive necrosis, hemolysis, and oliguric 
renal failure. If severe rhabdomyolysis has 
occurred, CPK levels will be markedly el-
evated within the first 12 hours post-enveno-
mation.1 Urine should be analyzed for myo-
globinuria and hemoglobinuria and renal 
function should be closely monitored for signs 
of renal failure. 
Treatment 
Pre·hospital. The treatment for snakebites 
in both humans and animals is surrounded 
by much folklore and anecdotal evidence of 
successful treatments. Even within the sci-
entific literature, there is much controversy 
regarding the most successful treatment pro-
tocols in these patients. The treatment the 
animal receives before it gets to the hospital 
can be important in the outcome of these cases. 
The most important recommendation for cli-
ents is to strictly limit the physical activity of 
the dog. The venom is spread through the 
lymphatics and excessive activity will increase 
the uptake of the venom.4 If an extremity is 
bitten, immobilization of the leg with a splint 
may be helpful if this can be rapidly per-
formed.2 Noting the levels of swelling every 
15 minutes during transport may help to de-
termine the degree of envenomation. It is not 
advisable to use a tourniquet to stop the 
spread of venom, pack the area in ice, or in-
cise the wound for suction. These practices 
have not proven useful and may cause fur-
ther injury.2 Recently the popular press has 
described electric shock therapy for treatment 
of poisonous snakebites. Scientific investiga-
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tion ofthis technique indicates that it is of no 
value and may actually be harmful to the ani-
mal. 6 Transporting the dog as quickly as pos-
sible to the nearest veterinary medical facil-
ity is the most prudent course of action to take 
Initial. Some patients may present in 
repiratory distress after envenomation by the 
Mojave rattlesnake or due to swelling around 
the upper airways. Emergency tracheotomy 
may be indicated in patients with extensive 
swelling in the neck area. After the airway is 
secured, intravenous fluid therapy is appro-
priate to support blood pressure and perfu-
sion.4,6 Since cardiovascular collapse due to 
hypovolemic shock is the primary cause of 
death, aggressive fluid therapy is indicated.1 
Colloids may be needed in severe cases. Six 
percent hetastarch in 0.9% sodium chloride 
has been recommended.6 However, hetastarch 
may be contraindicated if bleeding disorders 
are present because it prolongs prothrombin, 
partial thromboplastin, and clotting times.6 In 
addition, fresh whole blood, fresh plasma, or 
fresh frozen plasma, may be indicated for 
coagulopathies.4 
Pit viper envenomations can result in in-
tense pain for the patient. Analgesics may be 
warranted provided they do not cause respi-
ratory depression. Aspirin and other nonste-
roidal anti-inflammatory drugs with antico-
agulant effects should be avoided.4 In human 
medicine, patients have reported substantial 
analgesia from antivenin alone.6 
Antivenin. Once stabilized, the degree 
of envenomation should be evaluated by ana-
lyzing laboratory data and observing the se-
verity of systemic and local signs. Dogs that 
have moderate to severe degrees of enveno-
mation should receive antivenin as long as 
there is no history of anaphylaxis. The same 
antivenin (Antivenin [Crotalidae] Polyvalent 
[equine origin], Fort Dodge or Wyeth) is used 
to treat envenomation by all of the pit vipers. 
Copperhead envenomations have proven to be 
much less toxic than the other pit vipers and 
can usually be treated conservatively without 
the use of antivenin. 10 
Although the use of antihistamines is con-
troversial, many practitoners administer H 
blockers such as diphenhydramine to calm thJ 
animal and pretreat against allergic responses 
to the venom. 1 The antivenin package insert 
gives instructions on performing the skin test 
for horse serum sensitivity prior to adminis-
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tration. This test is simple to perform and 
should be utilized on all patients. However, it 
is not completely reliable and many false-posi-
tive and false-negative test results occur.1,2,6 
Initially, at least one vial of antivenin should 
be delivered intravenously. By comparison, 
as many as 20 vials of antivenin may be used 
in humans that have been bitten by rattle-
snakes.2 Due to the lack of venom dilution, 
smaller patients and patients that are bitten 
on digits may require 50% more antivenin 
than bites in larger animals or bites exclud-
ing digits.6 
The antivenin should be added to the in-
travenous f1 uids and delivered slowly over one 
or more hours while monitoring for signs of 
anaphylaxis. Hyperemia of the inner pinna 
is a good indicator of a systemic reaction.1 In 
mild cases of anaphylaxis, slowing the rate of 
administration may be all that is necessary 
to relieve the symptoms.6 Antihistamines are 
of little value unless given before the antive-
nin.6 Epinephrine is the drug of choice for 
anaphylaxis and should be readily available 
during treatment. If swelling increases, 
coagulopathies continue, or any other prob-
lem worsens, an additional vial of antivenin 
is probably warranted.2,6 Platelet numbers 
may be a good indicator of the progress to-
wards recovery for the patient during treat-
ment. 
The amount of time from envenomation 
to the delivery of the antivenin is crucial to 
the overall prognosis in these cases. It was 
found in a study of eastern diamondback 
rattlesnake (Crotalus adamanteus) enveno-
mation in dogs that if antivenin was given 30 
minutes after subcutaneous venom injection, 
eight out of eight dogs survived.6 If the anti-
venin was administered four hours after en-
venomation, five out of eight dogs survived; if 
given at eight hours, only one dog survived. 
Corticosteroids. The use of corticoster-
oids is the most controversial issue among cli-
nicians who treat pit viper envenomation. 
Support both for and against steroid use can 
be found in the literature. The majority of 
publications do not recommend the use of cor-
ticosteroids except in patients that are in 
shock or have had hypersensitivity reactions 
to the venom. Corticosteroids are not used to 
treat envenomation in human patients.2 His-
torically, corticosteroids have been the corner-
stone of treatment for venomous snakebites. 
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The ability to block the action of phospholi-
pase A , the major active component of most 
snake ~enom, would seem to be an advantage 
of steroid use.6 Disadvantages of corticoster-
oids include the impairment of wound heal-
ing, the masking of clinical signs and infec-
tions, the alteration of important laboratory 
data, and the possibility of interfering with 
the binding of antivenin to venom.1,2,6 
Antibiotics. It has been shown that a 
wide variety of both aerobic and anaerobic bac-
teria can be found as part of the natural flora 
of a snake's mouth. Bacteria of major con-
cern are Clostridium species and Pseudomo-
nas.6 The choice of antibiotic should be based 
on culture and sensitivity testing of the bite 
wound. Broad spectrum antibiotic therapy is 
recommended pending test results. 
Conclusion 
The diagnosis and treatment of pit viper en-
venomation in dogs can be very challenging. 
The wide variety of clinical signs and degrees 
of toxicity can make each case vastly differ-
ent in presentation and response to treatment. 
It is important for the clinician to be familiar 
with the pathophysiology of envenomation in 
order to understand the multisystemic effects 
that may be presented. The clinician should 
become knowledgeable about the poisonous 
Dr. Adams, continued from page 6. 
lab in large dumpsters, on that particular 
year, I managed to have Wolfgang wheel in 
a dumpster with me in it dressed up in a 
mask and such, and when he wheeled in the 
cart to freshman lab, I jumped out and 
scared all the freshman." 
Dr. Adams feels happy to have had a 
chance to provide laboratory instruction 
with not just embalmed cadavers but has 
been able to provide more fresh or non-em-
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snakes in the area and the idiosyncrasies of 
their venom components in order to make 
educated decisions regarding therapy for their 
victims. 
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balmed cadavers. 
Dr. Adams has been an almost institution 
for freshman veterinary students at the 
Iowa State University College of Veterinary 
Medicine and he will be sorely missed. We 
wish him good luck with future endeavors 
and we look forward to using the interac-
tive CD-ROM instructional programs. Best 
wishes with your move and enjoy the fish-
ing wherever it may take you!. 
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